首页 > 最新文献

Uroonkoloji Bulteni-Bulletin of Urooncology最新文献

英文 中文
Patolojik T2 Evreli Renal Hücreli Karsinom Olgularında Tümör Boyutunun Onkolojik Sonuçlar Üzerine Etkisi 肿瘤大小对病理性T2逆转肾细胞Carsinum肿瘤结果的影响
IF 0.2 Q4 ONCOLOGY Pub Date : 2017-03-07 DOI: 10.4274/UOB.780
Nurullah Hamidi, Evren Süer, Ilker Gökçe, Yaşar Bedük, Sümer Baltaci
{"title":"Patolojik T2 Evreli Renal Hücreli Karsinom Olgularında Tümör Boyutunun Onkolojik Sonuçlar Üzerine Etkisi","authors":"Nurullah Hamidi, Evren Süer, Ilker Gökçe, Yaşar Bedük, Sümer Baltaci","doi":"10.4274/UOB.780","DOIUrl":"https://doi.org/10.4274/UOB.780","url":null,"abstract":"","PeriodicalId":40816,"journal":{"name":"Uroonkoloji Bulteni-Bulletin of Urooncology","volume":"16 1","pages":"1-3"},"PeriodicalIF":0.2,"publicationDate":"2017-03-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70978213","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Kanserin Rengi Nedir 癌症是什么颜色的
IF 0.2 Q4 ONCOLOGY Pub Date : 2017-03-07 DOI: 10.4274/uob.795
Volkan Tatli, Oktay Üçer, T. Müezzinoğlu
{"title":"Kanserin Rengi Nedir","authors":"Volkan Tatli, Oktay Üçer, T. Müezzinoğlu","doi":"10.4274/uob.795","DOIUrl":"https://doi.org/10.4274/uob.795","url":null,"abstract":"","PeriodicalId":40816,"journal":{"name":"Uroonkoloji Bulteni-Bulletin of Urooncology","volume":"16 1","pages":"8-11"},"PeriodicalIF":0.2,"publicationDate":"2017-03-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70978252","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mesane Kanseri Erken Tanı ve Tedavisinde Toplumsal Farkındalık: Yaş ve Eğitim Düzeyinin Önemi Mesane癌症早期识别和社会识别:年龄和教育水平优先
IF 0.2 Q4 ONCOLOGY Pub Date : 2017-03-07 DOI: 10.4274/UOB.767
Doğan Değer, Öner Deniz Aslan, Kaan Çömez, Feyzullah Eren, Sedik Adırbelli, Güven Aslan
{"title":"Mesane Kanseri Erken Tanı ve Tedavisinde Toplumsal Farkındalık: Yaş ve Eğitim Düzeyinin Önemi","authors":"Doğan Değer, Öner Deniz Aslan, Kaan Çömez, Feyzullah Eren, Sedik Adırbelli, Güven Aslan","doi":"10.4274/UOB.767","DOIUrl":"https://doi.org/10.4274/UOB.767","url":null,"abstract":"","PeriodicalId":40816,"journal":{"name":"Uroonkoloji Bulteni-Bulletin of Urooncology","volume":"16 1","pages":"12-16"},"PeriodicalIF":0.2,"publicationDate":"2017-03-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70978343","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prostat Kanseri Tedavisinin Geleceği Apoptotik İndükleyicilerde mi 在凋亡供应商中前列腺癌症治疗的未来,
IF 0.2 Q4 ONCOLOGY Pub Date : 2017-03-07 DOI: 10.4274/UOB.606
Ece Konac, Sinan Sözen
{"title":"Prostat Kanseri Tedavisinin Geleceği Apoptotik İndükleyicilerde mi","authors":"Ece Konac, Sinan Sözen","doi":"10.4274/UOB.606","DOIUrl":"https://doi.org/10.4274/UOB.606","url":null,"abstract":"","PeriodicalId":40816,"journal":{"name":"Uroonkoloji Bulteni-Bulletin of Urooncology","volume":"16 1","pages":"22-27"},"PeriodicalIF":0.2,"publicationDate":"2017-03-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70977300","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Relationship between Bladder Cancer and Epigenetic Alterations 膀胱癌与表观遗传改变的关系
IF 0.2 Q4 ONCOLOGY Pub Date : 2017-03-01 DOI: 10.4274/uob.566
A. Ozen, A. Ülgen, C. Can
{"title":"The Relationship between Bladder Cancer and Epigenetic Alterations","authors":"A. Ozen, A. Ülgen, C. Can","doi":"10.4274/uob.566","DOIUrl":"https://doi.org/10.4274/uob.566","url":null,"abstract":"","PeriodicalId":40816,"journal":{"name":"Uroonkoloji Bulteni-Bulletin of Urooncology","volume":"16 1","pages":"17-21"},"PeriodicalIF":0.2,"publicationDate":"2017-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47100684","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk Factors for Urothelial Cancers 尿路上皮癌的危险因素
IF 0.2 Q4 ONCOLOGY Pub Date : 2016-09-30 DOI: 10.4274/uob.554
U. Gul, Barış Kuzgunbay
{"title":"Risk Factors for Urothelial Cancers","authors":"U. Gul, Barış Kuzgunbay","doi":"10.4274/uob.554","DOIUrl":"https://doi.org/10.4274/uob.554","url":null,"abstract":"","PeriodicalId":40816,"journal":{"name":"Uroonkoloji Bulteni-Bulletin of Urooncology","volume":"15 1","pages":"154-158"},"PeriodicalIF":0.2,"publicationDate":"2016-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70976708","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Bladder Leiomyoma in Men: Report of Two Cases and Review of the Literatüre 男性膀胱平滑肌瘤2例报告及文献复习[j]
IF 0.2 Q4 ONCOLOGY Pub Date : 2016-09-30 DOI: 10.4274/UOB.658
O. Cakmak, Sevgi Vermisli, O. Yalbuzdağ, D. Kahraman, S. Abdullazade
Benign mezenkimal tümörler tüm mesane tümörlerinin %1-5’ini oluşturur. Mesane leiomyomu mezenkimal kaynaklı nadir görülen benign tümördür (1,2). Semptomlar tümörün bulunduğu yer ve büyüklüğüne bağlı olarak değişiklik gösterebilir. Depolama semptomları, boşaltım semptomları ya da hematüri görülebilmektedir. Asemptomatik hastalarda radyolojik incelemeler sırasında insidental olarak da mesane leiomyomu saptanabilmektedir (1,3). Mesane leiomyomunun radyolojik değerlendirilmesi ultrasonografi (USG), bilgisayarlı tomografi (BT) veya manyetik rezonans inceleme (MRİ) ile yapılabilir (4). Tedavi modalitesi ise tümör lokalizasyonu ve boyutuna göre değişkenlik gösterebilir (2).
我的砾石肿瘤占所有网状肿瘤的%1-5。我的台面切开术是一种罕见的肿瘤来源(1.2)。症状会改变肿瘤的位置和大小。可以看到渗出症状、真空症状或血肿。在有症状的患者中,放射学检查包括中度骨髓瘤(1.3)。台面切开术的放射学评估可以通过超声(USG)、计算机断层扫描(BT)或磁共振成像(MRI)进行(4)。治疗模式可以根据肿瘤的位置和大小而改变(2)。
{"title":"Bladder Leiomyoma in Men: Report of Two Cases and Review of the Literatüre","authors":"O. Cakmak, Sevgi Vermisli, O. Yalbuzdağ, D. Kahraman, S. Abdullazade","doi":"10.4274/UOB.658","DOIUrl":"https://doi.org/10.4274/UOB.658","url":null,"abstract":"Benign mezenkimal tümörler tüm mesane tümörlerinin %1-5’ini oluşturur. Mesane leiomyomu mezenkimal kaynaklı nadir görülen benign tümördür (1,2). Semptomlar tümörün bulunduğu yer ve büyüklüğüne bağlı olarak değişiklik gösterebilir. Depolama semptomları, boşaltım semptomları ya da hematüri görülebilmektedir. Asemptomatik hastalarda radyolojik incelemeler sırasında insidental olarak da mesane leiomyomu saptanabilmektedir (1,3). Mesane leiomyomunun radyolojik değerlendirilmesi ultrasonografi (USG), bilgisayarlı tomografi (BT) veya manyetik rezonans inceleme (MRİ) ile yapılabilir (4). Tedavi modalitesi ise tümör lokalizasyonu ve boyutuna göre değişkenlik gösterebilir (2).","PeriodicalId":40816,"journal":{"name":"Uroonkoloji Bulteni-Bulletin of Urooncology","volume":"15 1","pages":"167-169"},"PeriodicalIF":0.2,"publicationDate":"2016-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70977251","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Immunohistochemical Study of Cyclooxygenase-2 Expression in Prostate Carcinoma: It’s Relation with Apoptosis and Angiogenesis 前列腺癌中环氧合酶-2表达的免疫组化研究:与细胞凋亡和血管生成的关系
IF 0.2 Q4 ONCOLOGY Pub Date : 2016-09-30 DOI: 10.4274/UOB.708
E. Bagir, A. Açıkalın, V. Izol, G. Seydaoglu, S. Erdoğan
Objective: Prostate carcinoma (PC) is one of the most commonly diagnosed cancer types with significant rates of mortality and morbidity. The etiology of PC is not clear. Cytokine and mediators at the inflammatory pathway plays role at the various steps of the relation between chronic inflammation and cancer. The objective of this study is to determine if there is relationship between cyclooxygenase-2 (COX) apoptosis and angiogenesis in patients with PC. Materials and Methods: Sample of 49 cases who were at pathologic stage pT2 and underwent radical prostatectomy, were selected retrospectively between 2005-2010, from the archives of Pathology Department of Çukurova University Faculty of Medicine. Histologic slides of each case were reviewed for the diagnostic reassessment and graded by the Gleason scoring system. COX-2, vascular endothelial growth factor (VEGF), monoclonal antibody (M30) and bcl-2 were immunohistochemically applied to the cases and they were evaluated. Results: The mean age of the patients were 63.8. Twenty-one cases had their Gleason score ≤6 and 28 had their Gleason score ≥7. COX-2 expression was detected in 81.6% of cases. While COX-2 expression was significantly correlated with bcl-2 expression, there was no correlation between VEGF and COX-2 expression. Gleason score was negatively correlated with M30. It was detected that as COX-2 expression increased mean survival time significantly decreased. Conclusion: This study makes us think that in the PC carcinogenesis COX2 inhibits apoptosis rather than promoting angiogenesis. These results may offer new insights for the treatment strategies, also they may be useful for the prediction of clinical outcomes.
目的:前列腺癌(PC)是诊断最常见的癌症类型之一,死亡率和发病率都很高。PC的病因尚不清楚。炎症通路上的细胞因子和介质在慢性炎症与癌症关系的各个环节发挥作用。本研究的目的是确定环氧化酶-2 (COX)凋亡与PC患者血管生成之间是否存在关系。材料与方法:回顾性选择2005-2010年Çukurova大学医学院病理科文献中病理分期pT2行根治性前列腺切除术的49例患者。对每个病例的组织学切片进行重新诊断评估,并根据Gleason评分系统进行评分。采用免疫组织化学方法检测COX-2、血管内皮生长因子(VEGF)、单克隆抗体(M30)和bcl-2。结果:患者平均年龄63.8岁。Gleason评分≤6分21例,≥7分28例。COX-2表达率为81.6%。COX-2表达与bcl-2表达有显著相关性,而VEGF与COX-2表达无相关性。Gleason评分与M30呈负相关。结果发现,随着COX-2表达量的增加,平均生存时间明显缩短。结论:本研究使我们认为在肝癌发生过程中,COX2抑制细胞凋亡而非促进血管生成。这些结果可能为治疗策略提供新的见解,也可能对临床结果的预测有用。
{"title":"Immunohistochemical Study of Cyclooxygenase-2 Expression in Prostate Carcinoma: It’s Relation with Apoptosis and Angiogenesis","authors":"E. Bagir, A. Açıkalın, V. Izol, G. Seydaoglu, S. Erdoğan","doi":"10.4274/UOB.708","DOIUrl":"https://doi.org/10.4274/UOB.708","url":null,"abstract":"Objective: Prostate carcinoma (PC) is one of the most commonly diagnosed cancer types with significant rates of mortality and morbidity. The etiology of PC is not clear. Cytokine and mediators at the inflammatory pathway plays role at the various steps of the relation between chronic inflammation and cancer. The objective of this study is to determine if there is relationship between cyclooxygenase-2 (COX) apoptosis and angiogenesis in patients with PC. Materials and Methods: Sample of 49 cases who were at pathologic stage pT2 and underwent radical prostatectomy, were selected retrospectively between 2005-2010, from the archives of Pathology Department of Çukurova University Faculty of Medicine. Histologic slides of each case were reviewed for the diagnostic reassessment and graded by the Gleason scoring system. COX-2, vascular endothelial growth factor (VEGF), monoclonal antibody (M30) and bcl-2 were immunohistochemically applied to the cases and they were evaluated. Results: The mean age of the patients were 63.8. Twenty-one cases had their Gleason score ≤6 and 28 had their Gleason score ≥7. COX-2 expression was detected in 81.6% of cases. While COX-2 expression was significantly correlated with bcl-2 expression, there was no correlation between VEGF and COX-2 expression. Gleason score was negatively correlated with M30. It was detected that as COX-2 expression increased mean survival time significantly decreased. Conclusion: This study makes us think that in the PC carcinogenesis COX2 inhibits apoptosis rather than promoting angiogenesis. These results may offer new insights for the treatment strategies, also they may be useful for the prediction of clinical outcomes.","PeriodicalId":40816,"journal":{"name":"Uroonkoloji Bulteni-Bulletin of Urooncology","volume":"15 1","pages":"144-147"},"PeriodicalIF":0.2,"publicationDate":"2016-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70977542","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Preoperative Factors Related to Stage and Grade Increase in D’Amico Low-Risk and Intermediate-Risk Group Patients D 'Amico低危和中危组患者术前分期和分级增加的相关因素
IF 0.2 Q4 ONCOLOGY Pub Date : 2016-09-30 DOI: 10.4274/UOB.738
S. Çelik, Ozan Bozkurt, O. Demir, B. Tuna, K. Yorukoglu, G. Aslan
{"title":"Preoperative Factors Related to Stage and Grade Increase in D’Amico Low-Risk and Intermediate-Risk Group Patients","authors":"S. Çelik, Ozan Bozkurt, O. Demir, B. Tuna, K. Yorukoglu, G. Aslan","doi":"10.4274/UOB.738","DOIUrl":"https://doi.org/10.4274/UOB.738","url":null,"abstract":"","PeriodicalId":40816,"journal":{"name":"Uroonkoloji Bulteni-Bulletin of Urooncology","volume":"15 1","pages":"148-153"},"PeriodicalIF":0.2,"publicationDate":"2016-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70977880","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Use of a Polytetrafluoroethylene Teflon Felt During Partial Nephrectomy 部分肾切除术中聚四氟乙烯聚四氟乙烯毡的使用
IF 0.2 Q4 ONCOLOGY Pub Date : 2016-09-30 DOI: 10.4274/uob.743
G. Aslan, A. Cihan, O. Cinar, O. Demir, A. Kefi, I. Celebi
{"title":"Use of a Polytetrafluoroethylene Teflon Felt During Partial Nephrectomy","authors":"G. Aslan, A. Cihan, O. Cinar, O. Demir, A. Kefi, I. Celebi","doi":"10.4274/uob.743","DOIUrl":"https://doi.org/10.4274/uob.743","url":null,"abstract":"","PeriodicalId":40816,"journal":{"name":"Uroonkoloji Bulteni-Bulletin of Urooncology","volume":"15 1","pages":"140-143"},"PeriodicalIF":0.2,"publicationDate":"2016-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70978321","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Uroonkoloji Bulteni-Bulletin of Urooncology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1